CPLX1 Antibody Blocking Peptide(bs-11341P)-500ug

CPLX1 Antibody Blocking Peptid

e(bs-11341P)-500ug
收藏
  • ¥880
  • Bioss已认证
  • bs-11341P
  • 2025年10月16日
    avatar
    品牌商
    9钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 规格

      500ug

    产品编号bs-11341P
    英文名称CPLX1 Antibody Blocking Peptide
    中文名称Complexin I/复合素1封闭多肽
    英文别名complexin 1; Complexin I; Complexin-1; CPLX1; CPLX1_HUMAN; CPX I; CPX-I; CPX1; Synaphin 2; Synaphin-2; 921-S.
    纯化方法HPLC
    研究领域

    Neuroscience > Cell Type Marker > Neuron marker > Synapse marker

    Neuroscience > Neurotransmission > Secretory Vesicles > SNAPs & SNAREs

    Signal Transduction > Protein Trafficking > Vesicle Transport > SNAPs & SNAREs

    亚基Binds to the SNARE core complex containing SNAP25, VAMP2 and STX1A.
    亚细胞定位Cytoplasm; cytosol. Enriched at synaptic-releasing sites in mature neurons.
    组织特异性Nervous system. In hippocampus and cerebellum, expressed mainly by inhibitory neurons. Overexpressed in substantia nigra from patients with Parkinson disease.
    相似性Belongs to the complexin/synaphin family.
    功能Positively regulates a late step in synaptic vesicle exocytosis. Also involved in glucose-induced secretion of insulin by pancreatic beta-cells.
    保存条件Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    注意事项This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    背景资料Complexin 1 and Complexin 2, also designated Synaphin 1 and Synaphin 2, contain an a-helical middle domain of approximately 58 amino acids. Complexin 1 and Complexin 2 are expressed in presynaptic terminals of inhibitory and excitatory hippocampal neurons, respectively, and in cytoplasmic pools during early stages of development. Complexins promote SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) precomplex formation by binding to synaxin with its a-helical domain. Complexins are important regulators of transmitter release at a late step in calcium dependent neurotransmitter release or immediately after the calcium-triggering step of fast synchronous transmitter release and preceding vesicle fusion. Neurons lacking complexins show reduced transmitter release efficiency due to decreased calcium sensitivity of the synaptic secretion process. Complexin 2 may play a role in LTP (long term potentiation) following tetanic stimulation. A progressive loss of Complexin 2 occurs in the brains of mice carrying the Huntington disease mutation, an autosomal dominant neurodegenerative disorder. Changes in the neurotransmitter release might contribute to the motor, emotional and cognitive dysfunctions seen in these mice.

     

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥880
    北京博奥森生物技术有限公司
    2025年10月16日询价
    ¥1680
    武汉博欧特生物科技有限公司
    2025年06月24日询价
    ¥700
    上海淳麦生物科技有限公司
    2025年04月07日询价
    ¥1680
    武汉琼格生物科技有限公司
    2025年05月13日询价
    ¥1680
    上海羽哚生物科技有限公司
    2025年05月20日询价
    CPLX1 Antibody Blocking Peptide(bs-11341P)-500ug
    ¥880